Jiaxi Li
Shanghai, 200032, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Potentiating BSEP-mediated bile acid efflux reverses first-line tyrosine kinase inhibitor resistance in hepatocellular carcinoma.
Journal: Cancer letters
Published: November 27, 2025
Programmed death-ligand 1 mediates triple-negative breast cancer metastasis and stemness through ten-eleven translocation 3.
Journal: International journal of biological macromolecules
Published: July 09, 2025
Correction: Dimethyl fumarate promotes the degradation of HNF1B and suppresses the progression of clear cell renal cell carcinoma.
Journal: Cell death & disease
Published: May 19, 2025
Oncometabolite fumarate facilitates PD-L1 expression and immune evasion in clear cell renal cell carcinoma.
Journal: Cell death & disease
Published: February 08, 2025
TET2 orchestrates YAP signaling to potentiate targetable vulnerability in hepatocellular carcinoma.
Journal: Cell death & disease
Published: November 07, 2024
LEAP2 ameliorates high fat diet-impaired glucose tolerance and enhances glucose-stimulated insulin secretion from β cells through PPARγ signal pathway.
Journal: Chinese medical journal
Published: October 09, 2023
Integrating metabolomics and network pharmacology to investigate Panax japonicus prevents kidney injury in HFD/STZ-induced diabetic mice.
Journal: Journal of ethnopharmacology
Published: October 05, 2022
Showing 1-9 of 9
Last Updated: 09/26/2026